Function Health’s New Erewhon Smoothie Was Designed to Highlight Nutritional Gaps and Promote Telehealth Lab Testing

Why It Matters

The launch ties real‑world product experience to Function's lab‑derived insights, accelerating user enrollment and reinforcing the business case for data‑driven nutrition interventions in telehealth.

Key Takeaways

• 65% users have high insulin levels
• 70% lack key nutrients like vitamin D
• Smoothie priced $16, includes coupon for new members
• Function valued $2.5B, 500k users, 160 tests
• Erewhon partnership expands retail presence for telehealth

Pulse Analysis

Function Health’s new Erewhon smoothie illustrates how telehealth firms are turning biometric data into tangible consumer products. By analyzing over 500,000 lab results, Function identified a striking prevalence of metabolic and micronutrient gaps—65% of users exhibit high insulin, a marker often missed in routine exams. This data-driven insight underscores a broader shift toward preventive care, where continuous monitoring and early detection become the foundation for personalized health strategies, challenging traditional episodic medical visits.

The collaboration with Erewhon leverages the retailer’s premium positioning to bring a science‑backed beverage to the grocery aisle. At $16 per bottle, the smoothie combines blueberries, greens, plant protein, omega‑rich oils, chia, flax and prebiotic fibers, directly addressing the deficiencies highlighted in Function’s reports. The added $25 discount for new members creates a seamless acquisition funnel, converting grocery shoppers into telehealth subscribers. This cross‑channel approach reflects a growing trend of health brands using retail touchpoints to expand their user base and gather additional lifestyle data.

Industry analysts see this partnership as a bellwether for the convergence of nutrition, technology, and retail. As consumers demand more actionable health insights, companies like Function are poised to monetize data through product collaborations, while retailers benefit from differentiated, health‑focused offerings. The model could spur further alliances, encouraging food manufacturers to embed clinical data into product development. In a market where 80% of users have at least one out‑of‑range biomarker, such integrative strategies may become a competitive imperative, reshaping how preventive health services are delivered and monetized.